BIOGRAPHY
Haoxiang (Harry H.X.) WANG [王皓翔] is a Professor at the School of Public Health, Sun Yat-Sen University. Harry holds an adjunct appointment at The Chinese University of Hong Kong (CUHK), Hong Kong SAR and an honorary appointment at The University of Edinburgh, UK. He is a Fellow of the International Society of Hypertension (ISH), UK and an International Fellow of the Japanese Society of Hypertension (JSH), Japan. His research focuses on modifiable risk factors, process of care, and its association with cardiovascular disease and multimorbidity, from epidemiology and health service perspectives.

Harry Hao-Xiang WANG gained a PhD in Public Health with 'The Best Ph.D. Thesis Award (2012)' at the JC School of Public Health and Primary Care, The Chinese University of Hong Kong (CUHK) in October 2012, and was immediately appointed as Lecturer at CUHK (2012-2015). While in Hong Kong he had a research attachment at the Department of Primary Health Care, University of Oxford, UK with an award received under the CUHK Global Scholarship Programme for Research Excellence (2010-11), and further carried out post-doctoral studies in multimorbidity at General Practice and Primary Care, University of Glasgow, UK with the Fellowship awarded under the Hong Kong-Scotland Partners in Post Doctoral Research (2012/13), launched by the Research Grants Council (RGC) of Hong Kong in collaboration with the Scottish Government, UK. He is now based in Guangzhou, P.R. China, where he has obtained a series of competitive grants as Principal Investigator, from the National Natural Science Foundation of China (NSFC) – a nationally-recognised funding agency – as well as other regionally-recognised academic funds.

Awarded Young Investigator Fellowship (Asian Pacific Society of Hypertension; 2012), Young Investigator Award (World Organization of Family Doctors [WONCA] Asia Pacific; 2015), and Distinguished Research Award (WONCA World; 2018), etc. He is on the Scientific Advisory Board for the International Academy of Cardiology (IAC) on the World Congress on Heart Disease, and is an External Referee for The Netherlands Organisation for Health Research and Development (ZonMw). He is also a Peer Reviewer for the Medical Research Council (MRC) and the National Institute for Health Research (NIHR), UK. He has recently been invited to serve as one of the five global panellists on 'National Healthcare Transformation: An International Perspective' at the WONCA Asia Pacific Regional Conference 2024 held in Singapore.

FACULTY APPOINTMENTS
▶ 2024.04–present, Professor, School of Public Health, Sun Yat-Sen University
▶ 2015.07–2024.04, Associate Professor, School of Public Health, Sun Yat-Sen University
▶ 2015.07–present, Adjunct Assistant Professor, JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR
▶ 2021.06–present, Honorary Fellow, Usher Institute, College of Medicine and Veterinary Medicine, The University of Edinburgh, Scotland, UK
▶ 2016.03–2021.03, Honorary Senior Lecturer (Public Health); Research Fellow (General Practice & Primary Care), Institute of Health and Wellbeing, University of Glasgow, Scotland, UK
▶ 2012.10–2015.07, Lecturer, JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR

EDUCATION & QUALIFICATIONS
▶ International Fellow, Japanese Society of Hypertension (2021)
▶ Fellow, International Society of Hypertension (2020)
▶ Fellow, Academy of Translational Medicine Professionals, European Society for Translational Medicine (2020)
▶ Fellow, Royal Society for Public Health (2016)
▶ Professional Member, International Society of Hypertension (2016)
▶ Postdoctoral Research Fellow, General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, UK (2013)
▶ Ph.D. in Public Health, JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR (2012)
▶ Research Fellow, International Society of Hypertension (2012)
▶ Visiting Scholar, Department of Primary Health Care, University of Oxford, UK (2011)

EXPERT POSITIONS

– Editorship
1. Associate Editor (Cardiovascular Epidemiology and Prevention), Frontiers in Cardiovascular Medicine (2022–present)
2. Editor, International Journal of Clinical Practice (2021–present)
3. Editor, Hong Kong Medical Journal (2017–present)
4. Editorial Board Member, Family Medicine and Community Health (2014–present)
5. (Lead) Guest Editor, Global Health Care for Long-Term Conditions and Multimorbidity [Special Issue], Journal of International Medical Research (2015–2016)
6. Guest Editor, Compliance with Prevention and Treatment for Hypertension and Related Cardiovascular Diseases [Special Issue], International Journal of Hypertension (2013)

– Adviser
1. Scientific Advisory Board, The International Academy of Cardiology and the 23rd/24th World Congress on Heart Disease, USA (2018; 2020)
2. Expert Panel, Health System Preparedness for Multiple Chronic Conditions, The Economist Intelligence Unit, UK (2019)
3. Session Panel, Multimorbidity in BRICS Countries (Brazil, Russia, India, China and South Africa), The Academy of Medical Sciences, UK (2017)

– Referee
1. Evaluation Panel, Best Original Research by Young Fellows, Hong Kong Academy of Medicine (2021-2024)
2. Peer Reviewer, Artificial Intelligence for Multiple Long-Term Conditions, National Institute for Health Research, UK (2021)
3. Peer Reviewer, Research and Innovation for Global Health Transformation, National Institute for Health Research, UK (2020)
4. Peer Reviewer, Multimorbidity 2018, Medical Research Council, UK (2018)
5. Peer Reviewer, Research Boards (Population & Systems Medicine Board), Medical Research Council, UK (2016)
6. Peer Reviewer, Clinician Scientist Fellowship Scheme, Medical Research Council, UK (2015)
7. External Referee, The Netherlands Organisation for Health Research and Development (ZonMw), Netherlands (2017)
8. Scientific Abstract Review Committee, The International Academy of Cardiology (IAC), Annual Scientific Sessions (2018)

Full peer review records available at: https://www.webofscience.com/wos/author/record/E-9027-2015


AWARDS & PRIZES
▶ Distinguished Research Award, World Organization of Family Doctors (WONCA) 22nd World Conference (2018)
▶ 'Faculty of the Year', 21st Cardiovascular Summit Transcatheter Cardiovascular Therapeutics Asia Pacific (TCTAP), CardioVascular Research Foundation (2016)
▶ Awarded Travel Grant, The 26th Scientific Meeting of the International Society of Hypertension (Hypertension Seoul 2016)
▶ Awarded Young Investigator Award, World Organization of Family Doctors (WONCA) 21st Asia Pacific Regional Conference (2015)
▶ Awarded Fellowship under the Hong Kong-Scotland Partners in Post Doctoral Research for 2012/13, Research Grants Council (RGC) of Hong Kong and the Scottish Government, UK (2013)
▶ Awarded 'The Best Ph.D. Thesis Award (2012)', School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong
▶ Awarded Young Investigator Travel Award, Asia-Pacific Academic Consortium for Public Health (2012)
▶ Awarded Young Investigator Fellowship of the Asian Pacific Society of Hypertension (2012)
▶ Awarded CUHK Global Scholarship Programme for Research Excellence – CNOOC Grant for 2010-11, The Chinese University of Hong Kong (2011)

RESEARCH & EDUCATION GRANTS
1. National Natural Science Foundation of China (grant NSFC-72061137002; NSFC-UKRI_ESRC), Principal Investigator (PI, China); in collaboration with UK Research and Innovation (UKRI) — the Economic and Social Research Council and the Medical Research Council (grant ES/T014164/1), Principal Investigator (PI, UK): Professor Stewart W. MERCER
2. National Natural Science Foundation of China (grant NSFC-71904212), PI
3. National Natural Science Foundation of China (grant NSFC-71673309), PI
4. Special Support Program of Guangdong Province (grant 2017TQ04R749), PI
5. Traditional Chinese Medicine Research Program of Guangdong Province (grant 20201055), PI
6. Basic and Applied Basic Research Foundation of Guangdong Province (grant 2019A1515011381), PI
7. Science and Technology Development Fund of Guangdong Province (grant 2016A020216006), PI
8. Open Research Funds of the State Key Laboratory of Ophthalmology (grant 303060202400377), PI
9. Open Research Funds of the State Key Laboratory of Ophthalmology (grant 303060202400362), PI
10. Fundamental Research Funds for Central Universities, PR China (grant SYSU-16ykzd10), PI
11. Research Grants Council (RGC) of Hong Kong and the Scottish Government, UK (grant S-CUHK402/12), PI
12. Higher Education Reform Project of Guangdong Province (grant 20191206-20), PI

PUBLICATIONS

  1. Mercer SW, Wang HHX. Chapter 2 Long-term Conditions. In: Staten A, Staten P, eds. Practical General Practice: Guidelines for Effective Clinical Management (7th edition). ISBN 978-0-7020-5552-2. Edinburgh, UK: Elsevier; 2019: 7-10.
  2. Heath I, Wang HHX, Mercer SW, Al-Habbal K, Osman M, Cubaka V, Cotton P. Chapter 13 International Perspectives. In: Watt GCM, ed. The Exceptional Potential of General Practice. ISBN 978-1-7852-3158-2. London, UK: CRC Press; 2018: 185-198. doi: 10.1201/9780429427640-13
  3. Wang HHX, Wang JJ. Chapter 40 Developing Primary Care in China. In: Griffiths SM, Tang JL, Yeoh EK, eds. Routledge Handbook of Global Public Health in Asia. ISBN 978-0-415-64382-5. London, UK: Routledge; 2014: 584-600. doi: 10.4324/9781315818719.ch40
  4. Wang HHX, Li YT, eds. Primary Health Care for Chronic Noncommunicable Diseases. ISBN 978-7-5359-7830-1. Guangzhou, PR China: Guangdong Foundation for Excellent Scientific and Technical Monograph Publishing/ Guangzhou, PR China: Guangdong Science & Technology Press; 2022.
  5. Wang HHX. Chapter 11 基層社區和農村衛生應急.  科學出版社“十四五”普通高等教育本科規劃教材《公共衛生應急》(李芳健,戴宇飛,王慧主編)［M］，ISBN 978-7-03-078054-6. Beijing, PR China: Science Press; 2024: 218-236.
  6. Wang HHX, Wu XY. Chapter 8 社區健康管理研究.  國家衛生健康委員會全科醫學規劃教材《全科醫生科研方法》(第3版 /劉民,杜娟主編)［M］，ISBN 978-7-117-34013-7. Beijing, PR China: People's Medical Publishing House; 2023: 241-265.
  7. Wang HHX. Chapter 10 社區衛生服務綜合評價研究.  國家衛生健康委員會全科醫學規劃教材《全科醫生科研方法》(第3版 /劉民,杜娟主編)［M］，ISBN 978-7-117-34013-7. Beijing, PR China: People's Medical Publishing House; 2023: 283-300.
  8. Wang HHX. Chapter 14 衛生保健策略.  高等學校“十四五”醫學規劃新形态教材／“十二五”普通高等教育本科國家級規劃教材《預防醫學》(第4版 /蔡泳主編)［M］，ISBN 978-7-04-058336-6. Beijing, PR China: Higher Education Press; 2022: 280-292.
  9. Wang HHX. Chapter 12 初級衛生保健服務評價研究.  國家衛生和計劃生育委員會全科醫生培訓“十三五”規劃教材《全科醫生科研方法》(第2版 /施榕,郭愛民主編)［M］，ISBN 978-7-117-24957-7. Beijing, PR China: People's Medical Publishing House; 2017: 270-284.
  10. Wang HHX. Chapter 14 健康管理.  國家衛生和計劃生育委員會全科醫生培訓“十三五”規劃教材《全科醫生科研方法》(第2版 /施榕,郭愛民主編)［M］，ISBN 978-7-117-24957-7. Beijing, PR China: People's Medical Publishing House; 2017: 311-329.
  11. Ding J, Wang HHX, Wang JH, Ren JJ, Qi DJ, Chen L, Luo YQ, Meng L, Jiang CY, Gu J, Liao XY, trans（副主譯 | 按姓氏筆畫排序）. In: Liang WN, Zhu SZ, Du XP, Yu XS, trans（主譯）/ Yang H, Han JJ, trans（執行主譯）. Murtagh's General Practice, 8th edition// Murtagh J, Rosenblatt J, Coleman J, Murtagh C, eds. ISBN 978-7-117-33774-8. Beijing, PR China: People's Medical Publishing House; 2023.
  12. Wang HHX, Wang JJ, trans. Chapter 7 Preventive Health Care// Campos-Outcalt D. In: Zeng YX, Chen Z, trans. Textbook of Family Medicine, 9th edition// Rakel RE, Rakel DP, eds. ISBN 978-7-117-27231-5. Elsevier (Singapore) Pte Ltd. and Beijing, PR China: People's Medical Publishing House; 2018: 97-117.
  13. Wang HHX, Wang JJ, trans. Chapter 27 Cardiovascular Disease// Toth PP, Shammas NW, Foreman B, Byrd JB, Brook RD. In: Zeng YX, Chen Z, trans. Textbook of Family Medicine, 9th edition// Rakel RE, Rakel DP, eds. ISBN 978-7-117-27231-5. Elsevier (Singapore) Pte Ltd. and Beijing, PR China: People's Medical Publishing House; 2018: 616-721.
  14. Wang HHX, Zhou Q, trans. Chapter 57 Community Health Promotion and Disease Prevention// Zaza S, Briss PA. In: Yin L, Wang LD, trans. Maxcy-Rosenau-Last Public Health & Preventive Medicine, 15th edition// Wallace RB, Kohatsu N, eds. ISBN 978-7-117-15316-4. McGraw-Hill Education (Asia) and Beijing, PR China: People's Medical Publishing House; 2012: 1151-1156.
  15. Wang HHX, Zhao Q, trans. Chapter 58 Risk Communication—An Overlooked Tool for Improving Public Health// Ropeik DP. In: Yin L, Wang LD, trans. Maxcy-Rosenau-Last Public Health & Preventive Medicine, 15th edition// Wallace RB, Kohatsu N, eds. ISBN 978-7-117-15316-4. McGraw-Hill Education (Asia) and Beijing, PR China: People's Medical Publishing House; 2012: 1157-1165.
  16. Chen J, Li YT*, Niu Z, He Z, Xie YJ, Hernandez J, Huang W*, Wang HHX*; on behalf of the Guangzhou Diabetic Eye Study Group. Does 10-year atherosclerotic cardiovascular disease risk predict incident diabetic nephropathy and retinopathy in patients with type 2 diabetes mellitus? Results from two prospective cohort studies in southern China. Diabetes Metab J. 2025;49(2):298-310. (*最後通訊)
  17. Wang HHX, Guo VY, Xie YJ, Li YT, Huang J, Wong MCS. COVID-19 responses in vulnerable populations: from clinical management to healthcare policies. Hong Kong Med J. 2024;30(6):434-436.
  18. Jia Z, Niu Z, Wang JJ, Hernandez J, Li YT*, Wang HHX*. Trajectories of treatment burden among primary care patients with long-term conditions in southern China: a latent class growth analysis. Risk Manag Healthc Policy. 2024;17:2009-2021. (*最後通訊)
  19. Chen J, Li YT*, Niu Z, He Z, Xie YJ, Hernandez J, Huang W*, Wang HHX*; Guangzhou Diabetic Eye Study Group. Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: a community-based prospective study. Diabetes Obes Metab. 2024;26(7):2796-2810. (*最後通訊)
  20. Cheng H, Jia Z, Li YT, Yu X, Wang JJ, Xie YJ, Hernandez J, Wang HHX*. Metabolic Score for Insulin Resistance and new-onset type 2 diabetes in a middle-aged and older adult population: nationwide prospective cohort study and implications for primary care. JMIR Public Health Surveill. 2024;10:e49617. (*最後通訊)
  21. Wang HHX, Li YT, Huang JJ, Zhang H, Huang W, Wong MCS. COVID-19: emerging trends, healthcare practice, artificial intelligence-assisted decision support, and implications for service innovation. Hong Kong Med J. 2024;30(1):7-9.
  22. Chen J, Li YT, Niu Z, He Z, Xie YJ, Hernandez J, Huang W, Wang HHX*; Guangzhou Diabetic Eye Study Group. Association of visceral obesity indices with incident diabetic retinopathy in patients with diabetes: prospective cohort study. JMIR Public Health Surveill. 2024;10:e48120. (*最後通訊)
  23. Wang HHX, Li YT, Huang J, Huang W, Wong MCS. Advances and opportunities in the new digital era of telemedicine, e-health, artificial intelligence, and beyond. Hong Kong Med J. 2023;29(5):380-382.
  24. Wang HHX, Li YT, Zhang H, Li JB, Huang W, Wong MCS. Reforming education and pedagogy in medicine and health with digital innovations to enhance learning practices and outcomes. Hong Kong Med J. 2023;29(3):192-194.
  25. Wang HHX, Li YT, Zhang Y, Wong MCS. Revisiting primary healthcare and looking ahead. Hong Kong Med J. 2023;29(2):96-98.
  26. Yu X, Li YT, Cheng H, Zhu SF, Hu XJ, Wang JJ, Mohammed BH, Xie YJ, Hernandez J, Wu HF*, Wang HHX*. Longitudinal changes in blood pressure and fasting plasma glucose among 5,398 primary care patients with concomitant hypertension and diabetes: an observational study and implications for community-based cardiovascular prevention. Front Cardiovasc Med. 2023;10:1120543. (*最後通訊)
  27. Wang HHX, Li YT, Duan H, Wong MCS. Physician motivation and satisfaction matter in healthcare. Hong Kong Med J. 2023;29(1):8-10.
  28. Yang HJ, Wu ZH, Huang X, Zhang M, Fu Y, Wu YJ, Liu L, Li YH*, Wang HHX*. In-hospital emergency treatment delay among Chinese patients with acute ischaemic stroke: relation to hospital arrivals and implications for triage pathways. Int J Gen Med. 2023;16:57-68. (*最後通訊)
  29. Wang HHX, Li YT, Wong MCS. Strengthening attributes of primary care to improve patients' experiences and population health: from rural village clinics to urban health centres. Hong Kong Med J. 2022;28(4):282-284.
  30. Yang HJ*, Huang X, Yang CY, Zhu SF, Chen XY, Zhang M, Yu X, Wang HHX*. Time window for acute stroke management: a cross-sectional study among community healthcare practitioners in primary care. Int J Gen Med. 2022;15:4483-4493. (*最後通訊)
  31. Wang HHX, Li YT, Wong MCS. Leveraging the power of health communication: messaging matters not only in clinical practice but also in public health. Hong Kong Med J. 2022;28(2):103-105.
  32. Hu XJ, Wang HHX*, Li YT, Wu XY, Wang Y, Chen JH, Wang JJ, Wong SYS, Mercer SW. Healthcare needs, experiences and treatment burden in primary care patients with multimorbidity: an evaluation of process of care from patients' perspectives. Health Expect. 2022;25(1):203-213. (*獨立通訊)
  33. Wang HHX, Mercer SW. Understanding barriers to adherence to optimal treatment of elevated blood pressure and hypertension-insights from primary care. JAMA Netw Open. 2021;4(12):e2138651.
  34. Wang Y, Hu XJ, Wang HHX*, Duan HY, Chen Y, Li YT, Luo ZL, Li X, Wang JJ, Mercer SW. Follow-up care delivery in community-based hypertension and type 2 diabetes management: a multi-centre, survey study among rural primary care physicians in China. BMC Fam Pract. 2021;22(1):224. (*獨立通訊)
  35. Wang Y, Wu XY, Wang HHX*, Li YT, Fu Y, Wang JJ, Hernandez J, Wong MCS. Body constitution and unhealthy lifestyles in a primary care population at high cardiovascular risk: new insights for health management. Int J Gen Med. 2021;14:6991-7001. (*獨立通訊)
  36. Wang HHX, Chen L, Ding HY, Huang JJ, Wong MCS. Scientific research on COVID-19 conducted in Hong Kong in 2020. Hong Kong Med J. 2021;27(4):244-246.
  37. Li YT, Wang Y, Hu XJ, Chen JH, Li YY, Zhong QY, Cheng H, Mohammed BH, Liang XL, Hernandez J, Huang W*, Wang HHX*. Association between systolic blood pressure and diabetic retinopathy in both hypertensive and normotensive patients with type 2 diabetes: risk factors and healthcare implications. Healthcare. 2021;9(5):580. (*最後通訊)
  38. Wang HHX. Taking a multidisciplinary team approach to better healthcare outcomes for society. Hong Kong Med J. 2020;26(6):551-552.
  39. Hu XJ, Wu HF, Li YT, Wang Y, Cheng H, Wang JJ, Mohammed BH, Tan I, Wang HHX*. Influence of health education on clinical parameters in type 2 diabetic subjects with and without hypertension: a longitudinal, comparative analysis in routine primary care settings. Diabetes Res Clin Pract. 2020;170:108539. (*最後通訊)
  40. Wang HHX, Wang JJ. Implications of evidence-based understanding of benefits and risks for cancer prevention strategy. Hong Kong Med J. 2019;25(5):346-348.
  41. Wong MCS, Wang HHX*, Kwan MWM, Li STS, Liang MY, Fung FDH, Yeung MS, Fong BCY, Zhang DX, Chan DKL, Yan BP, Coats AJS, Griffiths SM. The effectiveness of Dietary Approaches to Stop Hypertension (DASH) counselling on estimated 10-year cardiovascular risk among patients with newly diagnosed grade 1 hypertension: a randomised clinical trial. Int J Cardiol. 2016;224:79-87. (*獨立通訊)
  42. Wong MCS, Chan DKL, Wang HHX*, Tam WWS, Cheung CSK, Yan BP, Coats AJS. The incidence of all-cause, cardiovascular and respiratory disease admission among 20,252 users of lisinopril vs. perindopril: a cohort study. Int J Cardiol. 2016;219:410-416. (*獨立通訊)
  43. Wang HHX, Wang JJ, Wong SYS, Wong MCS, Mercer SW, Griffiths SM. The development of urban community health centres for strengthening primary care in China: a systematic literature review. Br Med Bull. 2015;116:139-153.
  44. Wong MCS, Wang HHX*, Kwan MWM, Fong BCY, Chan WM, Zhang DX, Li STS, Yan BP, Coats AJS, Griffiths SM. Dietary counselling has no effect on cardiovascular risk factors among Chinese Grade 1 hypertensive patients: a randomized controlled trial. Eur Heart J. 2015;36(38):2598-2607. (*獨立通訊)
  45. Wong MCS, Zhang DX, Wang HHX*. Rapid emergence of atherosclerosis in Asia: a systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies. Curr Opin Lipidol. 2015;26(4):257-269. (*最後通訊)
  46. Wang HHX, Wong SYS, Wong MCS, Wang JJ, Wei XL, Li DKT, Tang JL, Griffiths SM. Attributes of primary care in community health centres in China and implications for equitable care: a cross-sectional measurement of patients' experiences. QJM. 2015;108(7):549-560.
  47. Wang HHX, Wang JJ, Lawson KD, Wong SYS, Wong MCS, Li FJ, Wang PX, Zhou ZH, Zhu CY, Yeong YQ, Griffiths SM, Mercer SW. Relationships of multimorbidity and income with hospital admissions in 3 health care systems. Ann Fam Med. 2015;13(2):164-167.
  48. Wang HHX, Wang JJ, Wong SYS, Wong MCS, Li FJ, Wang PX, Zhou ZH, Zhu CY, Griffiths SM, Mercer SW. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China. BMC Med. 2014;12:188.
  49. Wang HHX, Wong SYS, Wong MCS, Wei XL, Wang JJ, Li DKT, Tang JL, Gao GY, Griffiths SM. Patients' experiences in different models of community health centers in southern China. Ann Fam Med. 2013;11(6):517-526.
  50. Wang HHX, Wang JJ, Wong SYS, Wong MCS, Li FJ, Wang PX, Zhou ZH, Zhu CY, Griffiths SM, Mercer SW. Effect of employment and social medical insurance on hospital admissions for people living with multimorbidity in China: analysis of a large community household survey. Lancet. 2015;386(Suppl 1):19-19. doi: 10.1016/S0140-6736(15)00597-8
  51. Wang HHX, Wang JJ, Wong SYS, Wong MCS, Wei XL, Li DKT, Tang JL, Griffiths SM. Patients' experiences in community health centres under the health-care reform: research findings from a cross-sectional study using the Primary Care Assessment Tool in China. Lancet. 2015;386(Suppl 1):69-69. doi: 10.1016/S0140-6736(15)00650-9
  52. 黃翔,梁家斌,楊華傑*,衛慶國,王皓翔*. 珠三角地區獨生子女與多子女老年人機構養老意願的影響因素分析［R］. 健康中國研究（第二輯）(王培剛主編)［M］，ISBN 978-7-5228-2101-6. 社會科學文獻出版社; 2023: 227-247. (*最後通訊)
  53. 王皓翔,王家骥. 廣州分級診療制度建設研究報告［R］. 廣州藍皮書：廣州社會發展報告（2019）(張躍國,尹濤主編/ 黃玉執行主編)［M］，ISBN 978-7-5201-4876-4. 社會科學文獻出版社; 2019: 66-81.
  54. 李東幸,牛紫敏,王皓翔*. 廣州市黃埔區老年人群健康體檢的回顧性隊列研究［J］. 中國全科醫學. 2025;28(13):1635-1641.［中文核心; 科技核心］(*最後通訊)
  55. 廖豔萍,李雲意,周志衡,王皓翔*. 65歲及以上老年人群中基于脂肪組織過多引起的慢性疾病患病情況及影響因素分析［J］. 中國全科醫學. 2024;27(19):2357-2363+2374.［中文核心; 科技核心］(*最後通訊)
  56. 楊華傑,黃翔,梁家斌,賈至慧,衛慶國,王皓翔*. 珠三角地區老年人養老需求、服務偏好及養老傾向的城鄉差異性分析［J］. 中國醫學科學院學報. 2024;46(2):193-203.［中文核心; 科技核心; CSCD］(*最後通訊)
  57. 廖豔萍,王皓翔*. 不同肥胖指标下深圳市坪山區老年人高血壓患病風險識别能力比較［J］. 醫學與社會. 2024;37(2):46-52.［中文核心; 科技核心］(*最後通訊)
  58. 朱俊志,盧偉焰,劉映芬,唐丹丹,杜麗詩,王皓翔*. 基于國際功能、殘疾和健康分類康複組合比較糖尿病合并與未合并腎病患者的功能狀态［J］. 中國醫學科學院學報. 2023;45(5):752-759.［中文核心; 科技核心; CSCD］(*最後通訊)
  59. 王皓翔. 基于初級衛生保健“5C”理念探索新時期高校“三全育人”特色培養模式的思考［專論］［J］. 全科醫學臨床與教育. 2023;21(7):577-580.［JST］
  60. 陽雨濛,吳小亞,範育玲,喻潇,李雲意,王皓翔*. 廣州市某社區精神障礙患者中醫藥服務首選意願及其影響因素［J］. 醫學與社會. 2023;36(1):134-139.［中文核心; 科技核心］(*最後通訊)
  61. 王怡,陳嘉珩,胡秀靜,王家骥,王皓翔*. 不同國家衛生技術評估應用現狀及對“健康中國”建設啟示［J］. 中國公共衛生. 2021;37(11):1713-1717.［中文核心; 科技核心; CSCD］(*最後通訊)
  62. 王皓翔*,黎宇婷,王怡,胡秀靜,張海峰,劉寬智,吳小亞,王家骥. 基于社區多重慢病防治教學與實踐的初級衛生保健人才培養探索［J］. 中國慢性病預防與控制. 2019;27(11):879-881.［中文核心; 科技核心; CSCD］(*獨立通訊)
  63. 胡秀靜,吳小亞,王家骥,王皓翔*. 慢性病防治視角下的我國醫養結合與健康管理發展回顧［衛生健康事業發展70年巡禮］［J］. 中國慢性病預防與控制. 2019;27(8):561-564.［中文核心; 科技核心; CSCD］(*最後通訊)
  64. 吳小亞,羅汀,李秋紅,張杏華,沈向東,胡秀靜,林榮榕,李淑冰,王家骥,王皓翔*. 我國社區全科醫生團隊簽約服務下的慢性病防治與實踐模式分析［J］. 中國慢性病預防與控制. 2018;26(11):877-880.［中文核心; 科技核心］(*最後通訊)
  65. 吳華鋒,溫彩銀,孔肖櫻,沈露,吳小亞,吳文偉,李秋泉,廖小铎,莫青艾,王家骥,王皓翔*. 基于家庭醫生服務的自我管理對城鄉結合地區糖尿病患者幹預效果的随機對照研究［J］. 中國全科醫學. 2018;21(26):3212-3216.［中文核心; 科技核心］(*最後通訊)


DOCTORAL SUPERVISION
100401 流行病與衛生統計學
107401 社會醫學與衛生事業管理
105300 公共衛生

IDENTIFIERS
▶ ORCID | https://orcid.org/0000-0002-0361-6527
▶ Publons | https://publons.com/researcher/1342803/harry-hx-wang/
▶ ResearchGate | https://www.researchgate.net/profile/Harry-Wang-7
▶ Scopus | https://www.scopus.com/authid/detail.uri?authorId=57207238718

EMAIL
wanghx27@mail.sysu.edu.cn | haoxiangwang@cuhk.edu.hk | v1hwan22@ed.ac.uk